Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc., the developer of the first rechargeable Sacral Neuromodulation (r-SNM™) System for the treatment of urinary and fecal ...

Welcome to the Axonics Q4 2020 Results Call. My name is Richard, and I'll be your operator for today's call. [Operator Instructions] I will now turn the call over to Neil Bhalodkar. You may begin.

As of March 24, 2023, the average one-year price target for Axonics Modulation Technologies is $84.09. The forecasts range from a low of $65.65 to a high of $94.50. The average price target represents ...

Fintel reports that on April 14, 2023, Mizuho initiated coverage of Axonics Modulation Technologies (NASDAQ:AXNX) with a Buy recommendation. As of April 6, 2023, the average one-year price target for ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) a medical technology company focused on the development and commercialization of novel implantable Sacral ...

Axonics Modulation Technologies (AXNX – Research Report) received a Hold rating and price target from Wolfe Research analyst Michael Polark yesterday. The company’s shares closed yesterday at $69.36.

In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Hold rating to Axonics Modulation Technologies (AXNX – Research Report), with a price target of $71.00. The company’s shares ...

Axonics Modulation Technologies Inc., of Irvine, Calif., reported revenue of $1.3 million for the third quarter of 2019, up from $0.2 million in the same period last year, but below Wall Street's ...

* AXONICS MODULATION TECHNOLOGIES INC - MOST EMPLOYEES WILL BE TAKING TEMPORARY 20% CUT IN BASE SALARY FOR REMAINDER OF Q2 2020 DUE TO COVID-19 IMPACT Sign up here. * AXONICS MODULATION TECHNOLOGIES - ...